18th Clinical Trials on Alzheimer's Disease (CTAD)

18th Clinical Trials on Alzheimer's Disease (CTAD) is organized by ANT Congress and will be held from Dec 01 - 04, 2025 at Hilton San Diego Bayfront, San Diego, California, United States of America.

Description:
CTAD25 will build on the momentum of previous years, reflecting the rapid advancements in Alzheimer’s disease diagnostics and therapeutics that make this field one of the most dynamic in medical research today.

CTAD25 also features thought-provoking roundtables and symposia that explore the latest advancements in AD research. Renowned clinicians and leaders from academia, research centers, patient coalitions, and pharmaceutical companies engage in dynamic discussions on diverse topics, from disease-modifying agents to gene therapy, vaccines, and multimodal interventions.

The CTAD scientific program is underpinned by a rigorous peer-review abstract selection process, ensuring the presentation of high-quality research that drives the field forward.